Active substances
Drospirenone + Ethinylestradiol
- SFDA 2
- US FDA 29
- Health Canada 9
- US price lines 9
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MIDIANA 3 mg/ 0.3 mg F.C.tablet | 3, 0.03 mg | Film-coated tablet · Oral use | 63 Blister | SAR 60.60 | Generic · Prescription | AJA PHARMACEUTICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
| YASMIN TAB. | 3, 0.03 mg | Film-coated tablet · Oral use | 21 Blister | SAR 23.75 | NCE · Prescription | BAYER PHARMA AG | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| YASMIN | 3MG;0.03MG | tablet · oral-28 | BAYER HLTHCARE | Prescription | 11 May 2001 |
| YAZ | 3MG;0.02MG | tablet · oral | BAYER HLTHCARE | Prescription | 16 Mar 2006 |
| YAZ | 3MG; 0.02MG | tablet · oral | BAYER HLTHCARE | Prescription | 4 Oct 2006 |
| YAZ | 3MG; 0.02MG | tablet · oral | BAYER HLTHCARE | Prescription | 26 Jan 2007 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.03MG | tablet · oral-28 | DR REDDYS LABS SA | Prescription | 7 Sep 2010 |
| LORYNA | 3MG;0.02MG | tablet · oral | XIROMED | Prescription | 28 Mar 2011 |
| SYEDA | 3MG;0.03MG | tablet · oral-28 | XIROMED | Prescription | 28 Mar 2011 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.02MG | tablet · oral | WATSON LABS | Prescription | 28 Nov 2011 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.03MG | tablet · oral-28 | LUPIN LTD | Prescription | 18 Dec 2012 |
| NIKKI | 3MG;0.02MG | tablet · oral | LUPIN | Prescription | 27 May 2014 |
| YAELA | 3MG;0.03MG | tablet · oral-28 | NOVAST LABS | Prescription | 19 Nov 2014 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.03MG | tablet · oral-28 | XIROMED | Prescription | 4 May 2015 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.02MG | tablet · oral | GLENMARK PHARMS LTD | Prescription | 17 Aug 2015 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.02MG | tablet · oral | XIROMED | Prescription | 22 Oct 2015 |
| MELAMISA | 3MG;0.02MG | tablet · oral | NOVAST LABS | Prescription | 26 Jan 2016 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.03MG | tablet · oral-28 | GLENMARK PHARMS LTD | Prescription | 25 Mar 2016 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.03MG | tablet · oral-28 | NAARI PTE | Prescription | 22 Nov 2016 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.02MG | tablet · oral | PHARMOBEDIENT | Prescription | 18 Jul 2017 |
| LO-ZUMANDIMINE | 3MG;0.02MG | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 27 Feb 2018 |
| ZUMANDIMINE | 3MG;0.03MG | tablet · oral-28 | AUROBINDO PHARMA LTD | Prescription | 26 Mar 2018 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.02MG | tablet · oral | HETERO LABS | Prescription | 22 Mar 2019 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.03MG | tablet · oral-28 | HETERO LABS | Prescription | 24 Jan 2020 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.03MG | tablet · oral-28 | BARR | Discontinued | 9 May 2008 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.02MG | tablet · oral | BARR | Discontinued | 30 Mar 2009 |
| DROSPIRENONE AND ETHINYL ESTRADIOL | 3MG;0.03MG | tablet · oral-28 | APOTEX | Discontinued | 21 Sep 2016 |
4 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP | 02462060 | 3 MG; 0.02 MG | TABLET · ORAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 21 | 02421437 | 0.03 MG; 3 MG | TABLET · ORAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP 28 | 02421445 | 3 MG; 0.03 MG | TABLET · ORAL | GLENMARK PHARMACEUTICALS CANADA INC. |
| MYA | 02415380 | 3.00 MG; 0.02 MG | TABLET · ORAL | APOTEX INC |
| YASMIN 21 | 02261723 | 0.03 MG; 3 MG | TABLET · ORAL | BAYER INC |
| YASMIN 28 | 02261731 | 0.03 MG; 3 MG | TABLET · ORAL | BAYER INC |
| YAZ | 02321157 | 3 MG; 0.02 MG | TABLET · ORAL | BAYER INC |
| ZAMINE 21 | 02410788 | 0.03 MG; 3 MG | TABLET · ORAL | APOTEX INC |
| ZAMINE 28 | 02410796 | 3 MG; 0.03 MG | TABLET · ORAL | APOTEX INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DROSPIRENONE-EE 3-0.02 MG TAB | $0.1909 | per EA | 23 Sep 2026 |
| US NADAC | DROSPIRENONE-EE 3-0.03 MG TAB | $0.15106 | per EA | 23 Sep 2026 |
| US NADAC | LO-ZUMANDIMINE 3 MG-0.02 MG TB | $0.1909 | per EA | 23 Sep 2026 |
| US NADAC | LORYNA 3 MG-0.02 MG TABLET | $0.1909 | per EA | 23 Sep 2026 |
| US NADAC | NIKKI 3 MG-0.02 MG TABLET | $0.1909 | per EA | 23 Sep 2026 |
| US NADAC | SYEDA 28 TABLET | $0.15106 | per EA | 23 Sep 2026 |
| US NADAC | YASMIN 28 TABLET | $4.39715 | per EA | 23 Sep 2026 |
| US NADAC | YAZ 28 TABLET | $5.84382 | per EA | 23 Sep 2026 |
| US NADAC | ZUMANDIMINE 3 MG-0.03 MG TAB | $0.15106 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Ethinylestradiol 20microgram / Drospirenone 3mg tablets | £14.70 | 84 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Ethinylestradiol 30microgram / Drospirenone 3mg tablets | £14.70 | 63 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.